{"add":{"doc":{"id":"2335393ee074b0aa7f7934b2a104cb5819f56ef276cfc269c1cdf2873a4699ed","url":"https://upload.wikimedia.org/wikipedia/commons/thumb/3/38/Stribild_bottle_Dutch_labeling.jpg/220px-Stribild_bottle_Dutch_labeling.jpg","previous":[],"after":["Current HAART options are combinations (or \"cocktails\") consisting of at least three medications belonging to at least two types, or \"classes,\" of antiretroviral agents.[131] Initially treatment is typically a non-nucleoside reverse transcriptase inhibitor (NNRTI) plus two nucleoside analogue reverse transcriptase inhibitors (NRTIs).[132] Typical NRTIs include: zidovudine (AZT) or tenofovir (TDF) and lamivudine (3TC) or emtricitabine (FTC).[132] Combinations of agents which include protease inhibitors (PI) are used if the above regimen loses effectiveness.[131]"]}}}